Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Pre-Open Movers 06/08: (JWN) (BABA) (VSTM) Higher; (NLNK) (GEF) (MZOR) Lower (more...)
-
Pre-Open Movers 04/20: (IMNP) (SCSS) (KCG) Higher; (PLXS) (WR) (PM) Lower (more...)
-
NewLink Genetics (NLNK) PT Raised to $32 at Cantor Fitzgerald
-
NewLink Genetics (NLNK) Enters $40M Stock Controlled Equity Offering Sales Agreement
-
NewLink Genetics to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
NewLink Genetics Reports First Quarter 2016 Financial Results
-
NewLink Genetics to Present at the Cantor Fitzgerald Healthcare Conference
-
NewLink Genetics (NLNK) Weakness Offers Opportunity, Cantor Fitzgerald Says
-
Cantor Fitzgerald Analyt Comments on NewLink Genetics (NLNK) CFO Change
-
NewLink (NLNK) Prices 4M Offering at $11.40/Share
-
Cantor Fitzgerald Raises PT and Estimates on NewLink Genetics (NLNK); Great Data at ASCO
-
Cantor Fitzgerald Starts NewLink Genetics (NLNK) at Buy; Late Stage Assets, Many Milestones
-
NewLink Genetics (NLNK) IPO Trades Higher
-
NewLink Genetics (NLNK) Prices 6.2M Share IPO at $7/Share

